Effects of Genetic Susceptibility for Type 2 Diabetes on the Evolution of Glucose Homeostasis Traits Before and After Diabetes Diagnosis
Data From the D.E.S.I.R. Study
- Alain Gautier1,
- Ronan Roussel2,
- Céline Lange3,4,
- Xavier Piguel1,
- Stéphane Cauchi5,
- Sylviane Vol6,
- Philippe Froguel5,7,
- Beverley Balkau3,4 and
- Fabrice Bonnet1⇓
- 1Service Endocrinologie, Centre Hospitalier Universitaire Rennes, Université Rennes 1, Hôpital Sud, INSERM U991, Rennes, France
- 2Université Paris 7, Hôpital Bichat, AP-HP, INSERM U695, Paris, France
- 3Centre de Recherche en Épidémiologie et Santé des Populations, INSERM U1018, Epidemiology of Diabetes, Obesity, and Chronic Kidney Disease Over the Life Course, Villejuif, France
- 4Université Paris-Sud 11, UMRS 1018, Villejuif, France
- 5Centre National de la Recherche Scientifique, UMR 8090, Institute of Biology, Lille 2 University, Pasteur Institute, Lille, France
- 6Institut inter Regional pour la Santé, La Riche, France
- 7Genomic Medicine, Hammersmith Hospital, Imperial College London, London, U.K.
- Corresponding author: Fabrice Bonnet, .
OBJECTIVE To assess the impact of genetic susceptibility on evolution toward type 2 diabetes (T2D) by analyzing time trajectories of fasting glucose, glycated hemoglobin (HbA1c), insulin sensitivity (homeostasis model assessment [HOMA2%S]), and β-cell secretion (HOMA2%B) in a large nondiabetic cohort. We also examined whether baseline HbA1c modified the effect of genetic predisposition on the time trajectories.
RESEARCH DESIGN AND METHODS Time trajectories were drawn in 4,744 participants from the French Data from an Epidemiological Study on the Insulin Resistance Syndrome (D.E.S.I.R.) cohort based on samples collected every 3 years over a 9-year follow-up. Trajectories were analyzed according to the TCF7L2 common variant, a family history of T2D, and a combination of at-risk alleles from nine T2D-associated genes.
RESULTS There was a marked decrease in HOMA2%B in parallel to a steep increase in HbA1c over the 3 years before incident diabetes, which was not influenced by genetic predisposition when considered alone. However, after the onset of T2D, the TCF7L2 at-risk variant was associated with a greater decrease in HOMA2%B. There was a joint effect of a family history of T2D with the presence of the TCF7L2 risk allele with a greater rise in HbA1c conferred by the coexistence of a family history and the T risk allele. An HbA1c ≥5.7% at baseline was associated with a greater increase in both glycemia and HbA1c levels in the presence of a combination of diabetes at-risk alleles.
CONCLUSIONS After incident T2D, TCF7L2 at-risk variants were associated with a faster decrease in β-cell function compared with those with the CC genotype. There was a joint effect of family history of T2D and TCF7L2 risk variant on the rise in glycemia and the decrease in insulin secretion at the end of follow-up, suggesting the joint influence of the combination of diabetes genetic predisposition with familial factors on the evolution of glycemia over time.
This article contains Supplementary Data online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db10-1442/-/DC1.
* A list of the members of the D.E.S.I.R. Study Group can be found in the appendix.
- Received October 11, 2010.
- Accepted July 11, 2011.
- © 2011 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.